PharmaPEG-GM-CSF (Mountain View Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePharmaPEG-GM-CSF (Mountain View Pharmaceuticals)
Drug Alias Namepegylated granulocyte-macrophage-colony stimulating factor (Mountain View Pharmaceuticals)pegylated GM-CSF (Mountain View Pharma)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulants
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsImmune System DiseasesHematologic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesHematologic Diseases

Other Information

ATC CodeN/A
Related LinksN/A